These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 21829658)

  • 1. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.
    Karolina DS; Armugam A; Tavintharan S; Wong MT; Lim SC; Sum CF; Jeyaseelan K
    PLoS One; 2011; 6(8):e22839. PubMed ID: 21829658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
    Mao ZJ; Weng SY; Lin M; Chai KF
    J Ethnopharmacol; 2019 Oct; 243():111966. PubMed ID: 31128151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.
    Kong L; Zhu J; Han W; Jiang X; Xu M; Zhao Y; Dong Q; Pang Z; Guan Q; Gao L; Zhao J; Zhao L
    Acta Diabetol; 2011 Mar; 48(1):61-9. PubMed ID: 20857148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
    Al-Rawaf HA; Alghadir AH; Gabr SA
    Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes.
    Herrera BM; Lockstone HE; Taylor JM; Ria M; Barrett A; Collins S; Kaisaki P; Argoud K; Fernandez C; Travers ME; Grew JP; Randall JC; Gloyn AL; Gauguier D; McCarthy MI; Lindgren CM
    Diabetologia; 2010 Jun; 53(6):1099-109. PubMed ID: 20198361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures.
    Greco M; Mirabelli M; Salatino A; Accattato F; Aiello V; Brunetti FS; Chiefari E; Pullano SA; Fiorillo AS; Foti DP; Brunetti A
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.
    Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Sideris DC; Fragoulis EG; Christodoulou MI
    Endocrine; 2019 Nov; 66(2):226-239. PubMed ID: 31559537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β Induction of miR-143/145 Is Associated to Exercise Response by Influencing Differentiation and Insulin Signaling Molecules in Human Skeletal Muscle.
    Dreher SI; Höckele S; Huypens P; Irmler M; Hoffmann C; Jeske T; Hastreiter M; Moller A; Birkenfeld AL; Häring HU; Peter A; Beckers J; Hrabě de Angelis M; Weigert C
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle.
    Massart J; Sjögren RJO; Lundell LS; Mudry JM; Franck N; O'Gorman DJ; Egan B; Zierath JR; Krook A
    Diabetes; 2017 Jul; 66(7):1807-1818. PubMed ID: 28404597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity.
    Krause C; Britsemmer JH; Bernecker M; Molenaar A; Taege N; Lopez-Alcantara N; Geißler C; Kaehler M; Iben K; Judycka A; Wagner J; Wolter S; Mann O; Pfluger P; Cascorbi I; Lehnert H; Stemmer K; Schriever SC; Kirchner H
    Elife; 2024 Jul; 12():. PubMed ID: 39037913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
    Cui X; You L; Zhu L; Wang X; Zhou Y; Li Y; Wen J; Xia Y; Wang X; Ji C; Guo X
    Metabolism; 2018 Jan; 78():95-105. PubMed ID: 28966078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-34a-5p and miR-452-5p: The Novel Regulators of Pancreatic Endocrine Dysfunction in Diabetic Zucker Rats?
    Su T; Hou J; Liu T; Dai P; Qin L; Ding L; Hu Y; Guo X
    Int J Med Sci; 2021; 18(14):3171-3181. PubMed ID: 34400887
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes.
    Herrera BM; Lockstone HE; Taylor JM; Wills QF; Kaisaki PJ; Barrett A; Camps C; Fernandez C; Ragoussis J; Gauguier D; McCarthy MI; Lindgren CM
    BMC Med Genomics; 2009 Aug; 2():54. PubMed ID: 19689793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes.
    Latouche C; Natoli A; Reddy-Luthmoodoo M; Heywood SE; Armitage JA; Kingwell BA
    PLoS One; 2016; 11(5):e0155108. PubMed ID: 27163678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.
    Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M
    Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.
    Vatandoost N; Amini M; Iraj B; Momenzadeh S; Salehi R
    Gene; 2015 Nov; 572(1):95-100. PubMed ID: 26164754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
    García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.
    Avgeris M; Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Scorilas A; Fragoulis EG; Christodoulou MI
    Diabetes Res Clin Pract; 2020 Jun; 164():108187. PubMed ID: 32360711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat.
    Esguerra JL; Bolmeson C; Cilio CM; Eliasson L
    PLoS One; 2011 Apr; 6(4):e18613. PubMed ID: 21490936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.